A novel cardiac glycoside monomer compound and its use in the preparation of antitumor drugs
A technique for cardiac glycosides and compounds, which is applied in the field of anti-tumor drug screening, can solve the problem that the anti-cancer activity of cardiac glycosides is poorly understood, and achieve the effects of strengthening in vitro anti-cancer activity, inhibiting cell proliferation, and inducing cell apoptosis.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0026] The present invention will be further described in detail below in conjunction with the accompanying drawings and through specific embodiments. The following embodiments are only descriptive, not restrictive, and cannot limit the protection scope of the present invention.
[0027] One, the present invention has confirmed through experiments that the novel cardiac glycoside monomer compound extracted from the traditional Chinese medicine Xiaotaoerqi has anticancer activity, and it is named HTF-1, the method is as follows:
[0028] First, the MTT assay was used to confirm that HTF-1 can induce apoptosis in human cervical cancer HeLa cells, human breast cancer MCF-7 cells, and human liver cancer HepG2 cells in a dose- and time-dependent manner.
[0029] Then HeLa cells were taken as the research object, and the apoptosis, cell cycle, proliferation, Migration, invasion, and the expression levels of related proteins.
[0030] The research results show that HTF-1 can inhibit...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com